Clinical aspects of Personalized Medicine in Human, Animal models

Personalized medicine is based on intraspecies differences. It is axiomatic that small differences in genetic make-up can result in dramatic differences in response to drugs or disease and Societal impact of personalized medicine. To express this in more general terms: in any given complex system, small changes in initial conditions can result in dramatically different outcomes. Despite human variability and intraspecies variation in other species, nonhuman species are still the primary model for ascertaining data for Personalized medicine health improvement in Human. We call this practice into question and conclude that human-based research should be the primary means for obtaining data about human diseases and responses to drugs. Strategies in the development and application of personalized medicine was developed for the accurate results in Personalized medicine health improvement in Human and Animal Models

  • Societal impact of personalized medicine - legal and ethical issues
  • Strategies in the development and application of personalized medicine
  • Personalized medicine health improvement in Human
  • Personalized medicine-approval process and marketing
  • Patents, guidelines, and regulatory affairs for personalized medicine
  • Clinical research of Personalized Medicine in Animal Models

Related Conference of Clinical aspects of Personalized Medicine in Human, Animal models

April 25-26, 2024

22nd European Pathology Congress

London, UK
August 21-22, 2024

4th World Pathology Conference

Amsterdam, Netherlands
September 23-24, 2024

22nd Annual Pathology Congress

Dubai, UAE

Clinical aspects of Personalized Medicine in Human, Animal models Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in